- Pages
- 5
- Published in
- United States of America
Premium
Pfizer Initiates Phase 3 Study of Mrna-Based
2024
<Macro 'access_denied_modal'>
<Macro 'unauthorized_modal'>
Add to list
Citation
Pfizer, Inc., 2024. Pfizer Initiates Phase 3 Study of Mrna-Based, Pfizer, Inc..
United States of America.
Retrieved from https://coilink.org/20.500.12592/2irac2e on 15 Nov 2024. COI: 20.500.12592/2irac2e.
Full-page Screenshot
